glp-1 vomiting legal team in kentucky class action nausea kentucky glp-1 lawsuit Kentucky Ozempic Lawsuit Lawyers Fact Check Team: How young – RFK Jr. says cyclospora outbreak

In January 2025, the Food and Drug Administration (FDA) approved a brand of semaglutide to reduce the risk of both cardiovascular death and worsening kidney disease in people with Type 2 diabetes and chronic kidney disease

Delayed Gastric Emptying: The medications slow down the emptying of the stomach, which can contribute to a feeling of fullness and reduced appetite

This precision matters when your dose changes week by week

However, its worth noting that the cost of oral medications goes up by $100/month if you need a higher dose

Ultimately, success depends on realistic expectations, ongoing monitoring, and a comprehensive treatment approach